The Methods of Pharmacognostic Observation of Raw Materials
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Specifications of Approved Drug Compound Library
Annexure-I : Specifications of Approved drug compound library The compounds should be structurally diverse, medicinally active, and cell permeable Compounds should have rich documentation with structure, Target, Activity and IC50 should be known Compounds which are supplied should have been validated by NMR and HPLC to ensure high purity Each compound should be supplied as 10mM solution in DMSO and at least 100µl of each compound should be supplied. Compounds should be supplied in screw capped vial arranged as 96 well plate format. -
Guava (Psidium Guajava L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities
foods Review Guava (Psidium guajava L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities Manoj Kumar 1 , Maharishi Tomar 2, Ryszard Amarowicz 3,* , Vivek Saurabh 4 , M. Sneha Nair 5, Chirag Maheshwari 6, Minnu Sasi 7, Uma Prajapati 4, Muzaffar Hasan 8, Surinder Singh 9, Sushil Changan 10 , Rakesh Kumar Prajapat 11, Mukesh K. Berwal 12 and Varsha Satankar 13 1 Chemical and Biochemical Processing Division, ICAR—Central Institute for Research on Cotton Technology, Mumbai 400019, India; [email protected] 2 ICAR—Indian Grassland and Fodder Research Institute, Jhansi 284003, India; [email protected] 3 Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima 10 Str., 10-748 Olsztyn, Poland 4 Division of Food Science and Postharvest Technology, ICAR—Indian Agricultural Research Institute, New Delhi 110012, India; [email protected] (V.S.); [email protected] (U.P.) 5 Department of Nutrition and Dietetics, Faculty of Allied Health Sciences, Manav Rachna International Institute of Research and Studies, Faridabad 121004, Haryana, India; [email protected] 6 Department of Agriculture Energy and Power, ICAR—Central Institute of Agricultural Engineering, Bhopal 462038, India; [email protected] 7 Division of Biochemistry, ICAR—Indian Agricultural Research Institute, New Delhi 110012, India; [email protected] 8 Agro Produce Processing Division, ICAR—Central Institute of Agricultural Engineering, Citation: Kumar, M.; Tomar, M.; Bhopal 462038, India; [email protected] 9 Amarowicz, R.; Saurabh, V.; Nair, Dr. S.S. Bhatnagar University Institute of Chemical Engineering and Technology, Panjab University, Chandigarh 160014, India; [email protected] M.S.; Maheshwari, C.; Sasi, M.; 10 Division of Crop Physiology, Biochemistry and Post-Harvest Technology, ICAR—Central Potato Research Prajapati, U.; Hasan, M.; Singh, S.; Institute, Shimla 171001, India; [email protected] et al. -
Phytopharmacological Overview of Psidium Guajava Linn
Pharmacogn. J. Review Article A multifaceted peer reviewed journal in the field of Pharmacognosy and Natural Products www.phcogfirst.com/phcogj Phytopharmacological overview of Psidium guajava Linn. Vijaya Anand1, Manikandan2, Vijaya Kumar2, Sampath Kumar3, Pushpa4, Agaath Hedina1 1Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore–641 046, Tamil Nadu, INDIA. 2Department of Biochemistry, M.I.E.T. Arts and Science College, Tiruchirappalli–620 007, Tamil Nadu, INDIA. 3Department of Chemistry and Biosciences, SASTRA University, Kumbakonam–612 001, Tamil Nadu, INDIA. 4Department of Microbiology, Cauvery College for Women, Tiruchirappalli–620 018, Tamil Nadu, INDIA. ABSTRACT Psidium guajava Linn. possesses useful medicinal benefits. It has been recognized as the medicinally essential phytoconstituents, such as pheno- Corresponding author: lic, flavonoid and carotenoid. Numerous pharmacological investigation have Dr. A. Vijaya Anand, confirmed that the ability of this plant is to exhibit antimicrobial, antidia- Associate Professor and Head, Department of Human Genetics and betic, cardioprotective, neuroprotective, hepatoprotective, antioxidant and Molecular Biology, Bharathiar University, Coimbatore–641 046, anticancer activities and it supports the traditional uses. This is a compre- Tamil Nadu, INDIA. hensive of the phytoconstituents and pharmacological benefits. Mobile: +91 9842525830 Key words: Psidium guajava, Antimicrobial, Antidiabetic, Antioxidant, Hep- E-mail: [email protected] atoprotective, Anticancer. DOI: 10.5530/pj.2016.4.3 INTRODUCTION (9Z)-, (13Z)-, and (15Z)-lycopene, (all-E,3R)-beta-cryptoxanthin, (all- E, 3R)-rubixanthin, (all-E,3S,5R,8S)-cryptoflavin, (all-E,3R,3’R, 6’R)- Psidium guajava Linn. is commonly called guave, goyave in French; lutein, (all-E,3S,5R,6R,3’S,5’R,8’R)-, and (all-E,3S,5R,6R,3’S, 5’R,8’S)- guave, guavenbaum, in German; banjiro in Japanese; goiaba, in Portu- neochrome.9 Guavanoic acid, guavacoumaric acid, 2α-hydroxyursolic 1 gal; arac¸ guaiaba in Brazil; and guava in English. -
The Phytochemistry of Cherokee Aromatic Medicinal Plants
medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs. -
CAS Number Index
2334 CAS Number Index CAS # Page Name CAS # Page Name CAS # Page Name 50-00-0 905 Formaldehyde 56-81-5 967 Glycerol 61-90-5 1135 Leucine 50-02-2 596 Dexamethasone 56-85-9 963 Glutamine 62-44-2 1640 Phenacetin 50-06-6 1654 Phenobarbital 57-00-1 514 Creatine 62-46-4 1166 α-Lipoic acid 50-11-3 1288 Metharbital 57-22-7 2229 Vincristine 62-53-3 131 Aniline 50-12-4 1245 Mephenytoin 57-24-9 1950 Strychnine 62-73-7 626 Dichlorvos 50-23-7 1017 Hydrocortisone 57-27-2 1428 Morphine 63-05-8 127 Androstenedione 50-24-8 1739 Prednisolone 57-41-0 1672 Phenytoin 63-25-2 335 Carbaryl 50-29-3 569 DDT 57-42-1 1239 Meperidine 63-75-2 142 Arecoline 50-33-9 1666 Phenylbutazone 57-43-2 108 Amobarbital 64-04-0 1648 Phenethylamine 50-34-0 1770 Propantheline bromide 57-44-3 191 Barbital 64-13-1 1308 p-Methoxyamphetamine 50-35-1 2054 Thalidomide 57-47-6 1683 Physostigmine 64-17-5 784 Ethanol 50-36-2 497 Cocaine 57-53-4 1249 Meprobamate 64-18-6 909 Formic acid 50-37-3 1197 Lysergic acid diethylamide 57-55-6 1782 Propylene glycol 64-77-7 2104 Tolbutamide 50-44-2 1253 6-Mercaptopurine 57-66-9 1751 Probenecid 64-86-8 506 Colchicine 50-47-5 589 Desipramine 57-74-9 398 Chlordane 65-23-6 1802 Pyridoxine 50-48-6 103 Amitriptyline 57-92-1 1947 Streptomycin 65-29-2 931 Gallamine 50-49-7 1053 Imipramine 57-94-3 2179 Tubocurarine chloride 65-45-2 1888 Salicylamide 50-52-2 2071 Thioridazine 57-96-5 1966 Sulfinpyrazone 65-49-6 98 p-Aminosalicylic acid 50-53-3 426 Chlorpromazine 58-00-4 138 Apomorphine 66-76-2 632 Dicumarol 50-55-5 1841 Reserpine 58-05-9 1136 Leucovorin 66-79-5 -
The Stimulant Higenamine in Weight Loss and Sports Supplements
Clinical Toxicology ISSN: 1556-3650 (Print) 1556-9519 (Online) Journal homepage: http://www.tandfonline.com/loi/ictx20 The stimulant higenamine in weight loss and sports supplements Pieter A. Cohen, John C. Travis, Peter H. J. Keizers, Frederick E. Boyer & Bastiaan J. Venhuis To cite this article: Pieter A. Cohen, John C. Travis, Peter H. J. Keizers, Frederick E. Boyer & Bastiaan J. Venhuis (2018): The stimulant higenamine in weight loss and sports supplements, Clinical Toxicology, DOI: 10.1080/15563650.2018.1497171 To link to this article: https://doi.org/10.1080/15563650.2018.1497171 View supplementary material Published online: 06 Sep 2018. Submit your article to this journal Article views: 4561 View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=ictx20 CLINICAL TOXICOLOGY https://doi.org/10.1080/15563650.2018.1497171 RESEARCH ARTICLE The stimulant higenamine in weight loss and sports supplements Pieter A. Cohena, John C. Travisb, Peter H. J. Keizersc, Frederick E. Boyerb and Bastiaan J. Venhuisc aDepartment of Internal Medicine, Harvard Medical School, Boston, MA, USA; bNSF International, Ann Arbor, MI, USA; cNational Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands ABSTRACT ARTICLE HISTORY Background: Higenamine is a stimulant with cardiovascular properties recently prohibited in sport by Received 5 June 2018 the World Anti-Doping Agency (WADA). Higenamine is also a natural constituent of several traditional Revised 27 June 2018 botanical remedies and is listed as an ingredient in weight loss and sports supplements sold over-the- Accepted 1 July 2018 counter in the United States. -
Ability of Higenamine and Related Compounds to Enhance Glucose Uptake in L6 Cells ⇑ Eisuke Kato , Shunsuke Kimura, Jun Kawabata
Bioorganic & Medicinal Chemistry 25 (2017) 6412–6416 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry journal homepage: www.elsevier.com/locate/bmc Ability of higenamine and related compounds to enhance glucose uptake in L6 cells ⇑ Eisuke Kato , Shunsuke Kimura, Jun Kawabata Laboratory of Food Biochemistry, Division of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Kita-ku, Sapporo, Hokkaido 060-8589, Japan article info abstract Article history: b2-Adrenergic receptor (b2AR) agonists are employed as bronchodilators to treat pulmonary disorders, Received 13 September 2017 but are attracting attention for their modulation of glucose handling and energy expenditure. Revised 2 October 2017 Higenamine is a tetrahydroisoquinoline present in several plant species and has b2AR agonist activity, Accepted 13 October 2017 but the involvement of each functional groups in b2AR agonist activity and its effectiveness compared Available online 14 October 2017 with endogenous catecholamines (dopamine, epinephrine, and norepinephrine) has rarely been studied. Glucose uptake of muscle cells are known to be induced through b2AR activation. Here, the ability to Keywords: enhance glucose uptake of higenamine was compared with that of several methylated derivatives of hige- b2-Adrenergic receptor namine or endogenous catecholamines. We found that: (i) the functional groups of higenamine except for Tetrahydroisoquinoline 0 Glucose uptake the 4 -hydroxy group are required to enhance glucose uptake; (ii) higenamine shows a comparable ability Muscle cell to enhance glucose uptake with that of epinephrine and norepinephrine; (iii) the S-isomer shows a Diabetes greater ability to enhance glucose uptake compared with that of the R-isomer. Ó 2017 Elsevier Ltd. All rights reserved. -
The Relaxation Effect and Mechanism of Action of Higenamine in the Rat Corpus Cavernosum
International Journal of Impotence Research (2012) 24, 77–83 & 2012 Macmillan Publishers Limited All rights reserved 0955-9930/12 www.nature.com/ijir ORIGINAL ARTICLE The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum SC Kam1,JMDo1, JH Choi1, BT Jeon2, GS Roh2, KC Chang3 and JS Hyun1 1Department of Urology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea; 2Department of Anatomy, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea and 3Department of Pharmacology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea Higenamine mediates cardiotonic, vascular relaxation and bronchodilator effects. The relaxation effects and the mechanism of action of higenamine on the rat corpus cavernosum (CC) were assessed to investigate the effect of higenamine on penile erection. Strips of CC and aorta were used in organ baths for isometric tension studies. Tension was measured with isometric force transducers, and muscle relaxation was expressed as the percent decrease in precontraction induced by phenylephrine (PE). The relaxation reactions were investigated in an endothelial-denuded group and groups pretreated with N(G)-nitro-L-arginine methyl ester (NO synthesis inhibitor), þ propranolol (b-receptor blocker), indomethacin (COX inhibitor), glibenclamide (KATP channel inhibitor), 4-aminopyridine (membrane potential-dependent potassium channel inhibitor) and methylene blue (guanylyl cyclase inhibitor) for 30 min. Intracavernous pressure (ICP) was assessed in rats after the intravenous administration of higenamine, and changes in guanosine 30,50-cyclic monophosphate and adenosine 30,50-cyclic monophosphate (cAMP) concentrations were measured on the basis of the higenamine concentration. -
Huang/11Herbal High" Controversy • Cacao to Chocolate Bookstore
HUANG/11HERBAL HIGH" CONTROVERSY • CACAO TO CHOCOLATE BOOKSTORE HERBAL PRESCRIPTIONS n;" l ~~· THE PROTOCOL JOURNAL FOR BETTER HEALTH OF BOTANICAL MEDICINE by Donald Brown. 1996. Discusses Ed . by Svevo Brooks. Compilation the most well researched herbal of botanical protocols from differing medicines ond effective herbal ... '.: :.':'~... ":.:, .. systems of traditional medicine _ ,_..;,.,... _ treatments for dozens of health providing therapeutic approaches to .... \l. j ...... , .. conditions. Including vitamins, specific disorders and condition minerals, ond herbs, each reviews with etiology, treatment SHIITAKE: prescription covers preparation, dosage, possible side effects, ond recommendations, diagnostic differentiations, medicine/ THE HEALING MUSHROOM cautions. Extensive references ond additional resources. treatment differentiations, toxicology, ond literature citations. by Kenneth Jones. 1995. Covers Hardcover. 349 pp. $22.95. #B183 Coli for information on specific volumes. Softcover. Vol. I No. nutritional value, history os ofolk 1, $25. #B182A; Vol. I No.2 ond forward, $48. #B182B{ medicine, usefulness in lowering cholesterol ond preventing heort disease, and its value in bolstering the immune system to increase the body's ability to prevent cancer, viral infections, and chronic fatigue syndrome. Softcover. THE BOOK OF PERFUME AROMATHERAPY: A 120 pp. $8.95. #B188 by E. Borille ond C. Laroze. 1995. COMPLETE GUIDE TO THE Beautifully illustrated volume HEALING ART includes sections on how the sense by K. Keville ond M. Green. 1995. THE BOOK OF TEA of smell works, the design of Topics include the history ond by A. Stello, N. Beautheac, G. perfume bottles, legendary theory of fragrance; therapeutic Brochard, and C. Donzel, translated perfumers, ond sources of row uses of aromotheropy for by Deke Dusinberre. -
Fireweed (Epilobium Angustifolium L.): Botany, Phytochemistry and Traditional Uses
DOI: 10.2478/hepo-2018-000 International journal edited by the Institute of Natural Fibres and Medicinal Plants Vol. 65 No. 3 2019 Received: 2019-08-01 DOI: 10.2478/hepo-2019-0018 DOI: 10.2478/hepo-2018-000 Accepted: 2019-09-20 Available online: 2019-09-30 REVIEW PAPER Fireweed (Epilobium angustifolium L.): botany, phytochemistry and traditional uses. A review ARTUR ADAMCZAK1*, MARIOLA DREGER2, KATARZYNA SEIDLER-ŁOŻYKOWSKA1, KAROLINA WIELGUS2 1Department of Botany, Breeding and Agricultural Technology of Medicinal Plants Institute of Natural Fibres and Medicinal Plants Kolejowa 2 62-064 Plewiska, Poland 2Department of Biotechnology Institute of Natural Fibres and Medicinal Plants Wojska Polskiego 71B 60-630 Poznań, Poland *corresponding author: phone: +48 (61) 665-95-50, e-mail: [email protected] Summary Fireweed (Epilobium angustifolium L., Onagraceae) is one of important medicinal plants used especially in the treatment of urogenital disorders, including benign prostatic hyperplasia (BPH) and prostatitis. The therapeutic effects of E. angustifolium extracts comprise antiproliferative, anti-inflammatory, immunomod- ulatory, antioxidant, and also antimicrobial activities. The aim of the present review was to provide the in- formation on the botany, phytochemistry and traditional uses of E. angustifolium. This plant is a widespread circumboreal species of North America and Eurasia, tolerant in terms of habitat conditions, and often oc- cupying man-made open habitats. Phytochemical studies on E. angustifolium resulted in the identification of about 250 different metabolites, including about 170 substances found for the first time in this plant in the last six years (2014–2019). Fireweed has an abundance of polyphenolic compounds, particularly ellagi- tannins. -
01 Contents Food Sheet No
CONTENTS 01 CONTENTS FOOD SHEET NO. TITLE PAGE SHEET NO. TITLE PAGE F001 Separation of Water-soluble Vitamins - 1 05 F069 Separation of Acesulfame K 25 F002 Separation of Water-soluble Vitamins - 2 05 F080 Separation of Aspartame and Acesulfame K in breath mint 25 F067 Separation of Vitamins 06 F049 Separation of Saccharin & Sorbic Acid 25 F005 Separation of Fat-soluble Vitamins 06 F076 Separation of Cyclamic acid 25 F070 Separation of Vitamin C 07 F051 Separation of Pyrazines 26 F003 Separation of Vitamin D2, D3 07 F089 Separation of Ubiquinone 9,10 26 F057 Separation of Tocopherols 07 F090 Separation of DL-Thioctic acid 26 F058 Separation of Vitamin C and E 08 F091 Separation of Benzoyl Peroxide in Flour 26 F097 Separation of Vitamin B12 in Health food 08 F053 Separation of Caffeine and Catechins 27 F071 Separation of Carotenoids 08 F054 Separation of Commercial Tea Drink 27 F004 Separation of β-Carotene in Broccoli 09 F055 Separation of Catechins 28 F059 Separation of β-Carotene 09 F056 Separation of Catechins, Caffeine, Chlorophyll a 28 F007 Separation of Synthetic Antibiotics (Quinolone Derivatives)-1 09 F063 Separation of Allyl isothiocyanate 29 F008 Separation of Synthetic Antibiotics (Quinolone Derivatives)-2 10 F064 Separation of Quassins 29 F009 Separation of Synthetic Antibiotics (Sulfa drugs) 10 F065 Separation of Capsaicins 29 F010 Separation of Synthetic Antibiotics (Furan Derivatives) 11 F082 Separation of Curcumin 29 F011 Separation of Synthetic Antibiotics (Protozoicides) 11 F083 Separation of Curcumin in a commercial -
WO 2018/002916 Al O
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/002916 Al 04 January 2018 (04.01.2018) W !P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C08F2/32 (2006.01) C08J 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, C08G 18/08 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/IL20 17/050706 HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (22) International Filing Date: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 26 June 2017 (26.06.2017) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 246468 26 June 2016 (26.06.2016) IL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: TECHNION RESEARCH & DEVEL¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, OPMENT FOUNDATION LIMITED [IL/IL]; Senate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, House, Technion City, 3200004 Haifa (IL).